Sustained-release implants in the chemotherapy of experimental rodent malaria I. A comparison of the effects of some antimalarials in polydimethylsiloxane matrices.
D000818:Animals; D000962:Antimalarials / Q000008:administration & dosage*; D002738:Chloroquine / Q000008:administration & dosage / Q000031:analogs & derivatives; D004129:Dimethylpolysiloxanes; D004343:Drug Implants; D008288:Malaria / Q000517:prevention & control*; D008297:Male; D015767:Mefloquine; D051379:Mice; D008815:Mice, Inbred Strains; D009285:Naphthoquinones / Q000008:administration & dosage; D010880:Piperidines / Q000008:administration & dosage; D010962:Plasmodium berghei; D011319:Primaquine / Q000008:administration & dosage; D002727:Proguanil; D011739:Pyrimethamine / Q000008:administration & dosage; D011804:Quinolines / Q000008:administration & dosage; D012826:Silicone Elastomers; D013411:Sulfadiazine / Q000008:administration & dosage; D014227:Triazines / Q000008:administration & dosage
D000962:Antimalarials; D004129:Dimethylpolysiloxanes; D004343:Drug Implants; D009285:Naphthoquinones; D010880:Piperidines; D011804:Quinolines; D012826:Silicone Elastomers; D014227:Triazines; D013411:Sulfadiazine; C026009:cycloguanil; C006201:BRL 6231; C023676:chloroquine diphosphate; D002738:Chloroquine; D011319:Primaquine; C001697:menoctone; D002727:Proguanil; D015767:Mefloquine; D011739:Pyrimethamine